|
| 36573552 | Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA. | J Pathol | 2023 |
| 37567793 | Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study. | Lancet Digit Health | 2023 |
| 36573552 | Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA. | J Pathol | 2023 |
| 37101220 | Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers. | Biomark Res | 2023 |
| 37567793 | Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study. | Lancet Digit Health | 2023 |
| 37101220 | Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers. | Biomark Res | 2023 |
| 35115040 | A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancer. | Clin Epigenetics | 2022 |
| 36313642 | A novel DNA methylation marker to identify lymph node metastasis of colorectal cancer. | Front Oncol | 2022 |
| 35646690 | Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer. | Front Oncol | 2022 |
| 35360854 | Editorial: Early Detection and Diagnosis of Cancer. | Front Genet | 2022 |
| 36457093 | Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers. | Clin Epigenetics | 2022 |
| 35115040 | A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancer. | Clin Epigenetics | 2022 |
| 35646690 | Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer. | Front Oncol | 2022 |
| 35360854 | Editorial: Early Detection and Diagnosis of Cancer. | Front Genet | 2022 |
| 36457093 | Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers. | Clin Epigenetics | 2022 |
| 36313642 | A novel DNA methylation marker to identify lymph node metastasis of colorectal cancer. | Front Oncol | 2022 |
| 34620221 | Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids. | Clin Epigenetics | 2021 |
| 33694305 | A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer. | Mol Oncol | 2021 |
| 33902700 | A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer. | Clin Epigenetics | 2021 |
| 33793424 | Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test. | J Clin Invest | 2021 |
| 33892797 | Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay. | Clin Epigenetics | 2021 |
| 34620221 | Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids. | Clin Epigenetics | 2021 |
| 34400642 | Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis. | NPJ Breast Cancer | 2021 |
| 33793424 | Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test. | J Clin Invest | 2021 |
| 33902700 | A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer. | Clin Epigenetics | 2021 |
| 33694305 | A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer. | Mol Oncol | 2021 |
| 33892797 | Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay. | Clin Epigenetics | 2021 |
| 34400642 | Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis. | NPJ Breast Cancer | 2021 |
| 32531444 | Identifying potential DNA methylation markers in early-stage colorectal Cancer. | Genomics | 2020 |
| 32420067 | DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model. | Transl Lung Cancer Res | 2020 |
| 32103545 | Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer. | FASEB J | 2020 |
| 33209621 | Evaluating the diagnostic accuracy of a ctDNA methylation classifier for incidental lung nodules: protocol for a prospective, observational, and multicenter clinical trial of 10,560 cases. | Transl Lung Cancer Res | 2020 |
| 32817589 | Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. | J Clin Invest | 2020 |
| 32531444 | Identifying potential DNA methylation markers in early-stage colorectal Cancer. | Genomics | 2020 |
| 32103545 | Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer. | FASEB J | 2020 |
| 33209621 | Evaluating the diagnostic accuracy of a ctDNA methylation classifier for incidental lung nodules: protocol for a prospective, observational, and multicenter clinical trial of 10,560 cases. | Transl Lung Cancer Res | 2020 |
| 32817589 | Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. | J Clin Invest | 2020 |
| 32420067 | DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model. | Transl Lung Cancer Res | 2020 |
| 26902887 | DNA methylation profiles in African American prostate cancer patients in relation to disease progression. | Genomics | 2019 |
| 31037156 | Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA). | Theranostics | 2019 |
| 26902887 | DNA methylation profiles in African American prostate cancer patients in relation to disease progression. | Genomics | 2019 |
| 31037156 | Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA). | Theranostics | 2019 |
| 28786531 | Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma. | Pigment Cell Melanoma Res | 2018 |
| 28786531 | Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma. | Pigment Cell Melanoma Res | 2018 |
| 30007336 | COL18A1 is a candidate eye iridocorneal angle-closure gene in humans. | Hum Mol Genet | 2018 |
| 29956356 | A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. | Prostate | 2018 |
| 29635542 | Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. | Ann Oncol | 2018 |
| 29589910 | Single-Cell Digital Lysates Generated by Phase-Switch Microfluidic Device Reveal Transcriptome Perturbation of Cell Cycle. | ACS Nano | 2018 |
| 29956356 | A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. | Prostate | 2018 |
| 30007336 | COL18A1 is a candidate eye iridocorneal angle-closure gene in humans. | Hum Mol Genet | 2018 |